SEC Form 4 · accession 0001209191-19-004552
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul M Silva
Officer — SVP & Corp Controller
Period of report
Jan 17, 2019
Accepted (ET)
Jan 18, 2019 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 17, 2019 | M | 1,289 | $91.05 | A | 17,376 | D | |
| Common Stock | Jan 17, 2019 | S | 1,289 | $191.05 | D | 16,087 | D | |
| Common Stock | Jan 17, 2019 | M | 859 | $90.29 | A | 16,946 | D | |
| Common Stock | Jan 17, 2019 | S | 859 | $190.29 | D | 16,087 | D | |
| Common Stock | Jan 17, 2019 | M | 859 | $90.29 | A | 16,946 | D | |
| Common Stock | Jan 17, 2019 | S | 859 | $190.29 | D | 16,087 | D | |
| Common Stock | holding | — | — | — | 169 | I | 401(K) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $91.05 | Jan 17, 2019 | M | 1,289 | D | — | Feb 1, 2026 | Common Stock | 1,289 | 6,446 | D |
| Stock Option (Right to Buy)F3 | $90.29 | Jan 17, 2019 | M | 859 | D | — | Jul 11, 2026 | Common Stock | 859 | 6,016 | D |
| Stock Option (Right to Buy)F3 | $90.29 | Jan 17, 2019 | M | 859 | D | — | Jul 11, 2026 | Common Stock | 859 | 5,157 | D |
Explanation of responses
- F1Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- F2The option vests in 16 quarterly installments from 02/02/2016.
- F3The option vests in 16 quarterly installments from 07/12/2016.